BIO-key International Inc. (NASDAQ:BKYI) Short Interest Update

BIO-key International Inc. (NASDAQ:BKYIGet Free Report) was the recipient of a significant decline in short interest in the month of July. As of July 15th, there was short interest totaling 1,399 shares, a decline of 68.4% from the June 30th total of 4,425 shares. Based on an average daily trading volume, of 34,947 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.1% of the company’s shares are short sold.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of BIO-key International in a research report on Friday, July 17th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, BIO-key International has a consensus rating of “Sell”.

Check Out Our Latest Report on BKYI

BIO-key International Price Performance

BKYI stock opened at $4.40 on Friday. The stock has a market capitalization of $4.80 million, a PE ratio of -0.79 and a beta of 0.43. The company’s 50-day moving average is $4.47 and its 200-day moving average is $5.44. BIO-key International has a 1 year low of $3.10 and a 1 year high of $19.70.

Institutional Investors Weigh In On BIO-key International

A hedge fund recently raised its stake in BIO-key International stock. Geode Capital Management LLC lifted its position in shares of BIO-key International Inc. (NASDAQ:BKYIFree Report) by 49.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 48,892 shares of the technology company’s stock after purchasing an additional 16,271 shares during the quarter. Geode Capital Management LLC owned 0.45% of BIO-key International worth $26,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 26.51% of the company’s stock.

About BIO-key International

(Get Free Report)

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.

Featured Stories

Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.